Correlation Between DiaMedica Therapeutics and Revance

Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Revance at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Revance into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between DiaMedica Therapeutics and Revance, you can compare the effects of market volatilities on DiaMedica Therapeutics and Revance and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Revance. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Revance.

Diversification Opportunities for DiaMedica Therapeutics and Revance

-0.42

Correlation Coefficient

DiaMedica Therapeutics  Revance

Very good diversification

The 3 months correlation between DiaMedica and Revance is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Revance in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revance and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Revance. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revance has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Revance go up and down completely randomly.

Pair Corralation between DiaMedica Therapeutics and Revance

Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.52 times more return on investment than Revance. However, DiaMedica Therapeutics is 1.92 times less risky than Revance. It trades about 0.16 of its potential returns per unit of risk. Revance is currently generating about -0.1 per unit of risk. If you would invest  389.00  in DiaMedica Therapeutics on September 3, 2024 and sell it today you would earn a total of  145.00  from holding DiaMedica Therapeutics or generate 37.28% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

DiaMedica Therapeutics  vs.  Revance

DiaMedica Therapeutics

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in DiaMedica Therapeutics are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather uncertain basic indicators, DiaMedica Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Revance

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Revance has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Pair Trading with DiaMedica Therapeutics and Revance

The main advantage of trading using opposite DiaMedica Therapeutics and Revance positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Revance can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revance will offset losses from the drop in Revance's long position.

The idea behind DiaMedica Therapeutics and Revance pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.